Exuma Biotech Company

EXUMA Biotech is a clinical-stage biotechnology company that focuses on discovering and developing CAR-T cell products for solid tumors.

Estimated Revenue: $1M to $10M
Funding Status: Early Stage Venture
Headquarters: Grand Cayman, Midland, Cayman Islands
Total Funding: 107000000
Last Funding Date: 2021-12-21
Investors Number: 7
Founded Date: 2015-01-01
Industry: CAR-T
Last Funding Type: Series B